Pharmaceutical
Biopharmaceutical
Manufacturing

Bristol-Myers Squibb

13,666

$59.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.62 (+1.05%) As of 8:54 AM EDT pre-market
+$0.62 (+1.05%) Pre-Market

Why Robinhood?

You can buy or sell BMY and other stocks, options, ETFs, and crypto commission-free!

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. Read More The company was founded in August 1933 and is headquartered in New York, NY.

CEO
Giovanni Caforio
Employees
30,000
Headquarters
New York, New York
Founded
1933
Market Cap
136.19B
Price-Earnings Ratio
73.10
Dividend Yield
2.91
Average Volume
19.48M
High Today
$60.58
Low Today
$58.87
Open Price
$59.79
Volume
8.81M
52 Week High
$68.34
52 Week Low
$42.48

Collections

Pharmaceutical
Biopharmaceutical
Manufacturing
Research And Development
Health
Biotechnology
Technology
Business Services

BMY News

Reuters24h

BRIEF-Dragonfly Therapeutics Announces Research Collaboration With Bristol Myers Squibb

July 6 (Reuters) - Bristol-Myers Squibb Co: * DRAGONFLY THERAPEUTICS ANNOUNCES NEW RESEARCH COLLABORATION WITH BRISTOL MYERS SQUIBB TO DEVELOP NOVEL THERAPEUTI
0
ReutersJul 1

From Parkinson's to peanut allergy, pandemic puts brakes on new drugs

(Reuters) - Treatments for peanut allergy and Parkinson’s disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers s
0

BMY Earnings

$0.00
$0.57
$1.15
$1.72
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Aug 6, Pre-Market

You May Also Like

EDU
CBRL
FDEM
KTF
LOGI
APEI
PSEC
VFC
MFC
EGLE
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy BMY

Market Price$59.76
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell BMY stock and options commission-free.
LearnBlogCareersHelpLog InSign Up